PKD1 and cancer: Interestingly, inspecting the PKD1 enhancer in the index of human DNaseI hypersensitive chromatin sites defined by Meuleman et al. [25] from 733 biosamples revealed that this site coincides with accessible chromatin only in two components: (i) renal/cancer and (ii) organ development/renal (electronic supplementary material, figure S3b).